Clinical Research Directory
Browse clinical research sites, groups, and studies.
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
Sponsor: Wake Forest University Health Sciences
Summary
The purpose of this study is to assess the incidence of early post-traumatic seizures. The study will also assess the benefit of lacosamide compared to levetiracetam in regards to agitation and behavioral adverse effects in patients with moderate to severe traumatic brain injury requiring seizure prophylaxis.
Official title: Comparison of Levetiracetam Versus Lacosamide for Seizure Prevention in Moderate to Severe Traumatic Brain Injured Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2025-04-18
Completion Date
2027-04
Last Updated
2026-02-06
Healthy Volunteers
No
Conditions
Interventions
levetiracetam
levetiracetam 1000 mg intravenously or by mouth twice daily for a total of 7 days
lacosamide
lacosamide 200 mg intravenously or by mouth twice daily for a total of 7 days
Locations (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States